Drug Discovery and Development: Technolas Perfect Vision GmbH

• Publication date: June 2012
• Report size: 28 pages

This report is a source for data, analysis and actionable intelligence on the Technolas Perfect Vision GmbH portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover data on product descript...

This report is a source for data, analysis and actionable intelligence on the Technolas Perfect Vision GmbH portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.

Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Ophthalmic Devices Industry in Germany

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Technolas Perfect Vision GmbH - Major Products and Services 5
Technolas Perfect Vision GmbH Pipeline Products by Equipment Type 6
Technolas Perfect Vision GmbH Pipeline Products by Development Stage 7
Technolas Perfect Vision GmbH Pipeline Products by Therapy Area 8
CUSTOMLENS 9
Product Status 9
Product Description 9
Product Milestone 9
Customshape 10
Product Status 10
Product Description 10
Intracor 10
Product Status 10
Product Description 10
SUPRACOR 11
Product Status 11
Product Description 11
Product Milestone 11
Technolas Perfect Vision GmbH - Top Competitors 12
Technolas Perfect Vision GmbH - Key Executives 13
Technolas Perfect Vision GmbH - Operations and Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Recent Developments 15
March 17, 2011: Technolas Perfect Vision Showcasing New All-Laser Femtosecond Cataract And Refractive System At ASCRS Meeting 15
March 14, 2011: Technolas Perfect Vision Receives FDA Approval For ZYOPTIX Advanced Nomogram 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16


List of Tables

Technolas Perfect Vision GmbH, Major development 1
Technolas Perfect Vision GmbH Key Pipeline Products by Equipment Type 1
Technolas Perfect Vision GmbH Key Pipeline Products by Therapy Area 1
Technolas Perfect Vision GmbH Key Pipeline Products by Development Stage 1
Technolas Perfect Vision GmbH Key Pipeline Products by Trial Phase 1
Technolas Perfect Vision GmbH, Major development 4
Technolas Perfect Vision GmbH, Major Products and Services 5
Technolas Perfect Vision GmbH Number of Pipeline Products by Equipment Type 6
Technolas Perfect Vision GmbH Pipeline Products by Equipment Type 6
Technolas Perfect Vision GmbH Number of Pipeline Products by Development Stage 7
Technolas Perfect Vision GmbH Pipeline Products by Development Stage 7
Technolas Perfect Vision GmbH Number of Pipeline Products by Therapy Area 8
Technolas Perfect Vision GmbH Pipeline Products by Therapy Area 8
CUSTOMLENS - Product Status 9
CUSTOMLENS - Product Description 9
CUSTOMLENS - Product Milestone 9
Customshape - Product Status 10
Customshape - Product Description 10
Intracor - Product Status 10
Intracor - Product Description 10
SUPRACOR - Product Status 11
SUPRACOR - Product Description 11
SUPRACOR - Product Milestone 11
Technolas Perfect Vision GmbH, Key Executives 13
Technolas Perfect Vision GmbH, Other Locations 14


List of Figures

Technolas Perfect Vision GmbH Pipeline Products by Equipment Type 6
Technolas Perfect Vision GmbH Pipeline Products by Development Stage 7
Technolas Perfect Vision GmbH Pipeline Products by Therapy Area 8

Companies mentioned Transinsight GmbH
Carl Zeiss Vision
Denzel Microsurgery
Acri Tec Gmbh
SEIKO Optical Europe GmbH
Retina Implant AG